drugset / Trial / NCT06548204
Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial
Phase 2
Not yet recruiting
165 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study was to evaluate the efficacy and safety of fexofenadine hydrochloride on the basis of standard treatment after PCI in STEMI patients.
Timeline
- Start
- 2024-09
- Primary completion
- 2026-03
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexofenadine | Unknown | 60 mg | — |
| Subject | Fexofenadine | Unknown | 120 mg | — |